Caris Life Sciences
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $168.0Mattributed |
|---|---|
| Latest round | seed, $168.0M, 2025-04-01attributed |
| Founded | 2008 |
| Headquarters | Irving TX |
| Industry | biotech|ai|diagnostics |
| Stage | series-b+ |
| Website | carislabusa.com |
Caris Life Sciences runs a molecular-diagnostics lab that profiles tumors across DNA, RNA, and protein for precision-oncology decisions. It serves oncologists and pharma partners stratifying patients by molecular drivers. Its Molecular Intelligence database links treatment outcomes to comprehensive molecular profiles in a longitudinal corpus rivals can't replicate.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-04-01 | seed | $168.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $168.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $168.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | carislabusa.com, read 2026-05-05 |
| Description | self-reported | carislabusa.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.